Kayali Sreelalitha, Chitra Thyagaraju, Kamalanathan Sadishkumar, Nandeesha Hanumanthappa
Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Int J Reprod Biomed. 2022 Apr 21;20(3):161-168. doi: 10.18502/ijrm.v20i3.10707. eCollection 2022 Mar.
Polycystic ovary syndrome (PCOS) is known to be associated with metabolic syndrome (MS). It is characterised by insulin resistance, hyperinsulinemia, dyslipidemia, obesity and hypertension. Data related to MS in infertile women with PCOS are limited in Indian populations.
This study aims to compare the prevalence of MS in infertile women with and without PCOS in a rural population in South India.
130 women with PCOS and 130 women without PCOS were enrolled in this cross-sectional study. A detailed history was taken and a physical examination was done for all women. Anthropometric parameters, a glucose tolerance test, fasting glucose / insulin levels, trigylcerides, high-density lipoprotein cholesterol and blood pressure were assessed in all participants. The International Diabetes Federation criteria were applied for assessment of MS.
MS was more prevalent in infertile women with PCOS (42.3%) compared to women without PCOS (19.3%). 56.9% of women with PCOS had low high-density lipoprotein cholesterol levels, 46.2% had high triglycerides, 71.5% had a high waist circumference, 31.5% had high blood pressure and 37.7% had high blood glucose levels. 26.0% of the women with PCOS had a healthy weight, and MS was seen in 6.9% of these women.
The prevalence of MS was higher in women with PCOS in comparison to women without PCOS. Among the women with PCOS, the prevalence of MS increased with age ( 27 yr), body mass index and waist circumference (71.5%), and even healthy women with PCOS contributed to 7% of MS. Hence it becomes necessary to screen all women with PCOS for metabolic profile risk factors at young age itself to prevent long term cardiovascular complications.
多囊卵巢综合征(PCOS)已知与代谢综合征(MS)相关。其特征为胰岛素抵抗、高胰岛素血症、血脂异常、肥胖和高血压。在印度人群中,关于患有PCOS的不孕女性的代谢综合征数据有限。
本研究旨在比较印度南部农村地区患有和未患有PCOS的不孕女性中代谢综合征的患病率。
130名患有PCOS的女性和130名未患有PCOS的女性参与了这项横断面研究。对所有女性进行了详细的病史采集和体格检查。评估了所有参与者的人体测量参数、葡萄糖耐量试验、空腹血糖/胰岛素水平、甘油三酯、高密度脂蛋白胆固醇和血压。采用国际糖尿病联盟标准评估代谢综合征。
与未患有PCOS的女性(19.3%)相比,患有PCOS的不孕女性中代谢综合征更为普遍(42.3%)。56.9%的患有PCOS的女性高密度脂蛋白胆固醇水平较低,46.2%甘油三酯较高,71.5%腰围较大,31.5%血压较高,37.7%血糖水平较高。26.0%的患有PCOS的女性体重正常,其中6.9%患有代谢综合征。
与未患有PCOS的女性相比,患有PCOS的女性中代谢综合征的患病率更高。在患有PCOS的女性中,代谢综合征的患病率随年龄(≥27岁)、体重指数和腰围(71.5%)增加,甚至体重正常的患有PCOS的女性中也有7%患有代谢综合征。因此,有必要在年轻时就对所有患有PCOS的女性进行代谢谱风险因素筛查,以预防长期心血管并发症。